Key Documents
Andrei Iagaru
Academic Appointments
- Clinical Instructor, Radiology - Nuclear Medicine
Contact Information
-
Clinical Offices
Nuclear Medicine 300 Pasteur Dr H0101 MC 5281 Stanford, CA 94305 Tel Work (650) 725-4711 Fax (650) 498-5047Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Administrative Contact Mary Troyer Administrative Assistant Email Tel Work 6507254711Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Nuclear Medicine
- Positron-Emission Tomography
- Radioimmunotherapy
Honors and Awards
- Best Essay Award, American College of Nuclear Medicine (2010)
- Norman D. Poe Memorial Scholarship Award, Western Regional Society of Nuclear Medicine (2009)
- Developmental Cancer Research Award, Stanford Cancer Center (2009)
- Image of the Year, Society of Nuclear Medicine (2009)
- Alavi-Mandell Award, Society of Nuclear Medicine (2009)
Professional Education
| Fellowship: | Stanford University Medical Center, CA (2007) |
| Board Certification: | Nuclear Medicine, American Board of Nuclear Medicine (2006) |
| Residency: | Stanford University Medical Center, CA (2006) |
| Residency: | USC - Keck School of Medicine, CA (2005) |
| Internship: | Graduate Hospital, PA (2004) |
Graduate & Fellowship Program Affiliations
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | MediGene |
Scientific Focus
Current Research Interests
Current research projects include: 1) Whole-Body MRI and PET/CT for Early Cancer Detection; 2) Zevalin/Bexxar Radioimmunotherapy; 3) Optical Imaging of Breast Cancer; 4) Clinical Translation of Novel PET Radiopharmaceuticals; and 5) PET-CT Imaging for Thyroid/Breast Cancer, Melanoma, Lymphoma, and Sarcoma.
Clinical Trials
- 18 F-fluoride PET/CT versus 99Tc-MDP Scanning for Detecting Bone Metastases Recruiting
- Adjunctive Efficacy Study Of The SoftScanŽ Optical Breast Imaging System Recruiting
- Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project Recruiting
- Combined F18 and F18 FDG PET/CT for Evaluation of Malignancy Recruiting
- PET/CT and Whole-Body MRI for Detection of Skeletal and Soft Tissue Metastases Recruiting
Publications
- Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma. Hell J Nucl Med. 2009 Jan-Apr; (1): 26-9
- Tumor Metabolic Phenotypes on 18F FDG PET. J Nucl Med. 2009
- (131)I-Tositumomab (Bexxar(R)) vs. (90)Y-Ibritumomab (Zevalin(R)) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma. Mol Imaging Biol. 2009
- Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol. 2009; (5): 606-13
- Combined 18F-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? J Nucl Med. 2009
Help